Pune, India

Kiran Ashok Kulkarni

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiran Ashok Kulkarni. Retrieved from https://idiyas.com/inventor/kiran-ashok-kulkarni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiran Ashok Kulkarni: Innovator in Pharmaceutical Chemistry

Introduction

Kiran Ashok Kulkarni is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address blood-related disorders. His innovative work has the potential to impact the treatment of conditions such as sickle cell anemia.

Latest Patents

Kiran holds a patent for "Decalin derivatives, a process for the preparation and pharmaceutical composition thereof." This patent includes decalin derivative compounds of formula (I), along with processes for their preparation and pharmaceutical compositions. The methods outlined in the patent provide a means for treating blood-related disorders in subjects in need of such treatment.

Career Highlights

Kiran is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the application of scientific principles to real-world health challenges.

Collaborations

Kiran collaborates with esteemed colleagues, including Suhag Sanjay Patil and Paresh Ramesh Athawale. These partnerships enhance the scope and impact of his research endeavors.

Conclusion

Kiran Ashok Kulkarni's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing critical health issues. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of blood-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…